rs34668322

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001122681.2(SH3BP2):​c.1332G>A​(p.Ser444Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000576 in 1,589,610 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S444S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0030 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00032 ( 2 hom. )

Consequence

SH3BP2
NM_001122681.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.12

Publications

2 publications found
Variant links:
Genes affected
SH3BP2 (HGNC:10825): (SH3 domain binding protein 2) The protein encoded by this gene has an N-terminal pleckstrin homology (PH) domain, an SH3-binding proline-rich region, and a C-terminal SH2 domain. The protein binds to the SH3 domains of several proteins including the ABL1 and SYK protein tyrosine kinases , and functions as a cytoplasmic adaptor protein to positively regulate transcriptional activity in T, natural killer (NK), and basophilic cells. Mutations in this gene result in cherubism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
SH3BP2 Gene-Disease associations (from GenCC):
  • cherubism
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 4-2831661-G-A is Benign according to our data. Variant chr4-2831661-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 454492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.12 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.003 (457/152254) while in subpopulation AFR AF = 0.0105 (436/41534). AF 95% confidence interval is 0.00968. There are 2 homozygotes in GnomAd4. There are 230 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 457 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SH3BP2NM_001122681.2 linkc.1332G>A p.Ser444Ser synonymous_variant Exon 9 of 13 ENST00000503393.8 NP_001116153.1 P78314-1A0A384N6E5
SH3BP2NM_001145856.2 linkc.1503G>A p.Ser501Ser synonymous_variant Exon 9 of 13 NP_001139328.1 P78314-4
SH3BP2NM_001145855.2 linkc.1416G>A p.Ser472Ser synonymous_variant Exon 9 of 13 NP_001139327.1 P78314-3
SH3BP2NM_003023.4 linkc.1332G>A p.Ser444Ser synonymous_variant Exon 9 of 13 NP_003014.3 P78314-1A0A384N6E5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SH3BP2ENST00000503393.8 linkc.1332G>A p.Ser444Ser synonymous_variant Exon 9 of 13 1 NM_001122681.2 ENSP00000422168.3 P78314-1

Frequencies

GnomAD3 genomes
AF:
0.00299
AC:
455
AN:
152136
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0105
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000649
AC:
135
AN:
207880
AF XY:
0.000489
show subpopulations
Gnomad AFR exome
AF:
0.00984
Gnomad AMR exome
AF:
0.000386
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000224
Gnomad OTH exome
AF:
0.000378
GnomAD4 exome
AF:
0.000319
AC:
459
AN:
1437356
Hom.:
2
Cov.:
32
AF XY:
0.000300
AC XY:
214
AN XY:
713028
show subpopulations
African (AFR)
AF:
0.0105
AC:
346
AN:
32828
American (AMR)
AF:
0.000452
AC:
19
AN:
41998
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25740
East Asian (EAS)
AF:
0.000183
AC:
7
AN:
38238
South Asian (SAS)
AF:
0.0000480
AC:
4
AN:
83304
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50872
Middle Eastern (MID)
AF:
0.000696
AC:
4
AN:
5744
European-Non Finnish (NFE)
AF:
0.0000118
AC:
13
AN:
1099246
Other (OTH)
AF:
0.00111
AC:
66
AN:
59386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
31
61
92
122
153
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00300
AC:
457
AN:
152254
Hom.:
2
Cov.:
32
AF XY:
0.00309
AC XY:
230
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.0105
AC:
436
AN:
41534
American (AMR)
AF:
0.00105
AC:
16
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68012
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
22
44
67
89
111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00144
Hom.:
0
Bravo
AF:
0.00351
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fibrous dysplasia of jaw Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Dec 11, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.016
DANN
Benign
0.49
PhyloP100
-2.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34668322; hg19: chr4-2833388; COSMIC: COSV100696940; COSMIC: COSV100696940; API